Study Finds 66% of Cancer Patients Experienced Symptom Relief From Medical Marijuana

Introduction

For many cancer patients, some of the most debilitating side effects of treatment are nausea, vomiting, and loss of appetite. Chemotherapy and radiation can take a severe toll on quality of life, often leading to weight loss, malnutrition, and overall weakness. Traditional medications, while helpful for some, don’t always bring relief. Increasingly, patients are turning to medical marijuana as a complementary therapy—and many report significant improvements in controlling nausea and regaining their appetite.

According to the Journal of the National Cancer Institute Monographs, cannabis and cannabinoids are increasingly being used by cancer patients for pain, nausea, appetite stimulation, anxiety, and sleep support. While research is ongoing, patient experiences and clinical studies suggest that marijuana may play a vital role in supportive cancer care.

This article explores how cannabis works in the body, reviews scientific evidence on its impact on nausea and appetite, and highlights patient perspectives.

Medical Marijuana for cancer Patients

Why Nausea and Appetite Loss Are Major Issues in Cancer Care

Cancer patients often battle two intertwined challenges: chemotherapy-induced nausea and vomiting (CINV) and cachexia (a syndrome of appetite loss and muscle wasting).

  • Nausea & Vomiting: Chemotherapy drugs are highly emetogenic, meaning they frequently trigger nausea and vomiting. Even with antiemetic drugs, many patients still experience these symptoms. This can lead to anticipatory nausea, where patients feel sick just thinking about treatment.

  • Loss of Appetite & Cachexia: Up to 80% of patients with advanced cancer develop anorexia or cachexia. Appetite loss is more than an inconvenience—it is associated with shorter survival rates and reduced tolerance to treatment.

For patients, these side effects can feel overwhelming, compounding the stress of cancer itself. That’s why the search for effective symptom management—including natural alternatives like cannabis—has intensified.

How Medical Marijuana Works for Nausea and Appetite

The reason medical marijuana shows so much promise for nausea and appetite loss in cancer patients lies in its ability to interact with the endocannabinoid system (ECS), a network of receptors and signaling molecules that plays a key role in regulating appetite, mood, pain, and gastrointestinal function. When patients undergo chemotherapy or radiation, the balance of this system can be disrupted, leading to overwhelming nausea and a sharp decline in appetite. Cannabis compounds, particularly THC (tetrahydrocannabinol) and CBD (cannabidiol), act on these pathways to restore balance and ease symptoms.

THC: The Appetite and Anti-Nausea Driver

THC is the primary psychoactive compound in cannabis and is largely responsible for its reputation as an appetite stimulant. It binds directly to CB1 receptors located in areas of the brain that control hunger and food intake, including the hypothalamus. By activating these receptors, THC stimulates the release of hunger-related hormones and enhances the brain’s sensitivity to food cues. This explains why many patients report the “munchies” after using cannabis—a sudden desire to eat even when they previously had little or no appetite.

When it comes to nausea, THC exerts its benefits by dampening the release of excitatory neurotransmitters in both the brain and gut. Chemotherapy triggers nausea and vomiting by overstimulating certain regions of the brainstem and gastrointestinal tract. THC, by acting on CB1 receptors, calms these overactive signals, reducing both the urge to vomit and the sensation of queasiness.

CBD: The Balancing Compound

CBD, while not psychoactive, plays a complementary role. Research suggests it interacts with serotonin receptors (particularly 5-HT1A) that influence nausea and anxiety. By modulating serotonin activity, CBD can reduce anticipatory nausea—when patients feel sick before treatment even begins—and promote a sense of calm.

Additionally, CBD may counteract some of THC’s stronger psychoactive effects, making cannabis therapy more tolerable for patients who are sensitive to THC. While high doses of CBD are often needed for noticeable effects, its anti-inflammatory and anxiolytic properties may support overall symptom relief when combined with THC.

Related: CBD vs. THC: How Do They Differ?

The Entourage Effect: More Than Just THC and CBD

Cannabis is not a single-compound medicine. It contains over 400 chemical compounds, including cannabinoids, terpenes, and flavonoids, that work together synergistically—a phenomenon known as the entourage effect. Terpenes like limonene (uplifting, citrus-scented) and linalool (calming, lavender-scented) may enhance anti-nausea and anti-anxiety effects, while cannabinoids such as CBG (cannabigerol) and CBC (cannabichromene) may provide additional appetite support.

This synergy helps explain why some patients find whole-plant cannabis preparations more effective than isolated compounds. A THC:CBD combination, for example, may deliver stronger nausea relief and a smoother appetite boost than either compound alone.

A Dose-Dependent Response

It’s important to note that cannabis has biphasic, or dose-dependent effects. At low to moderate doses, THC can ease nausea and encourage eating. At higher doses, however, THC may cause dizziness, anxiety, or even worsen nausea. For this reason, oncologists and cannabis specialists recommend the principle of “start low and go slow,” allowing patients to carefully titrate their dose until they find the therapeutic sweet spot without unwanted side effects.

While conventional antiemetics and appetite stimulants exist, cannabis offers something unique: it addresses both nausea and appetite loss simultaneously. Patients often describe cannabis as not only calming their stomach but also restoring their interest in food. Beyond its direct effects, cannabis can also ease related symptoms such as anxiety, depression, and sleep disturbance, creating a holistic improvement in quality of life that traditional medications often cannot match.

study finds 66% of cancer patients benefitted from medical marijuana

Research Evidence: Medical Marijuana for Nausea Relief

One of the most extensively studied uses of medical marijuana is its ability to reduce nausea and vomiting in cancer patients, particularly those undergoing chemotherapy. These symptoms are not only distressing but can also lead to malnutrition, dehydration, and interruptions in treatment. For decades, researchers have explored how cannabis and its active compounds can ease these side effects—and the evidence continues to grow.

Early Clinical Trials

As far back as the 1970s, clinical trials tested THC in comparison with standard anti-nausea drugs. In several small but pivotal studies, THC showed superior relief from chemotherapy-induced nausea and vomiting (CINV). For instance, one early randomized controlled trial reported that patients given oral THC experienced significantly fewer vomiting episodes compared with placebo, and in some cases, even more benefit than conventional antiemetics available at the time. These findings prompted the eventual development of synthetic THC medications such as dronabinol (Marinol) and nabilone (Cesamet), both of which are FDA-approved for treating chemotherapy-related nausea.

Modern Evidence and Combination Therapies

More studies have examined not only THC but also combinations of THC and CBD. Nabiximols (Sativex), an oral spray containing both cannabinoids in a 1:1 ratio, has been tested in cancer patients who did not respond well to traditional therapies. Some studies found that adding nabiximols improved nausea relief and patient satisfaction, especially when used alongside standard antiemetics. Importantly, patients often reported preferring cannabis-based treatments, even if mild side effects like dizziness or drowsiness occurred, because the relief was more noticeable.

Patient-Reported Outcomes

Beyond controlled trials, real-world surveys provide valuable insights. Across multiple observational studies, a large percentage of cancer patients say cannabis helps reduce their nausea and improve treatment tolerance. May also state that cannabis feels more natural and holistic compared to pharmaceutical options. Interestingly, some patients reported discontinuing or reducing prescription anti-nausea medications after beginning cannabis therapy, highlighting its potential as either a complementary or alternative treatment.

Limitations and Gaps in Research

While the evidence is promising, experts caution that many studies have limitations, including small sample sizes, difficulty in blinding (patients can often tell whether they’ve received cannabis), and variability in cannabis strains and dosages. Additionally, cannabinoids can cause side effects such as dizziness, fatigue, or mild euphoria, which may affect tolerability for certain patients. More large-scale randomized controlled trials are still needed to establish precise dosing guidelines and determine which patient populations benefit the most.

Why This Matters

Despite these gaps, the current body of research provides strong support for cannabis as an effective adjunct therapy for managing nausea in cancer care. For patients who have exhausted conventional antiemetic options, or who suffer from breakthrough nausea despite standard treatment, medical marijuana offers a much-needed alternative. The consistency of both clinical data and patient-reported experiences makes a compelling case that cannabis deserves a central role in ongoing cancer symptom management research.

Research Evidence: Medical Marijuana for Appetite Stimulation

Cannabis has been used for centuries as an appetite enhancer. In fact, studies as early as the 1970s noted that cannabis use reduced chemotherapy-induced nausea and vomiting.

Key Studies

  • A 1994 open-label trial reported that cancer patients experienced improved appetite with THC.

  • In one large trial, megestrol acetate (a progestational drug) outperformed dronabinol for appetite stimulation, but patients still reported cannabis provided more enjoyable eating experiences.

  • Other trials revealed mixed results—while some found THC effective, others suggested that cancer patients may respond differently than healthy individuals.

Despite limitations, many patients continue to report improved appetite and food enjoyment when using cannabis, even if weight gain is modest.

The Biphasic Effect: Why Dosing Matters

One critical factor with cannabis is its dose-dependent effect:

  • Low doses of THC may relieve nausea and stimulate appetite.

  • High doses of THC can sometimes worsen anxiety, nausea, or appetite suppression.

This is  why most  experts recommend the principle of “start low, go slow”, gradually increasing dosage until the therapeutic window is found.

Forms of Medical Marijuana for Cancer Patients

One of the strengths of medical marijuana as a supportive therapy in cancer care is its versatility in delivery methods. Patients can choose from several forms of cannabis depending on their needs, preferences, and tolerance. Each method comes with its own set of advantages and drawbacks, making it important for patients—ideally under the guidance of a medical professional—to select the option that works best for them.

1. Inhalation: Smoking and Vaporizing

Inhalation is the fastest-acting method, with effects usually felt within minutes. This makes it especially useful for sudden waves of nausea or when patients struggle with vomiting and need quick relief. While smoking dried cannabis flower remains common, many patients and clinicians prefer vaporization, which heats cannabis at lower temperatures to release cannabinoids and terpenes without combustion. Vaporizing reduces exposure to harmful toxins and is considered a safer alternative to smoking. However, for patients with compromised lung function or those undergoing radiation to the chest, inhalation may not be the best choice.

2. Oral Ingestion: Capsules, Oils, and Edibles

Edible forms of cannabis—such as capsules, infused oils, and baked goods—are popular for their convenience and long-lasting effects. Once ingested, cannabinoids pass through the digestive system and liver before entering the bloodstream, leading to a delayed onset (30 minutes to 2 hours) but extended relief that can last 6 to 8 hours or more. This makes edibles particularly helpful for ongoing appetite stimulation or for patients who need sustained symptom control throughout the day. The downside is that oral absorption can be unpredictable, and some patients may find it difficult to titrate doses precisely.

3. Sublingual Tinctures and Sprays

For patients who want the fast onset of inhalation without smoking or vaping, sublingual delivery is an excellent option. Cannabis tinctures, lozenges, or sprays are placed under the tongue and absorbed directly into the bloodstream through the mucous membranes. Relief can begin within 15–30 minutes, offering a middle ground between inhalation and edibles. These methods also allow for more precise dosing, making them ideal for patients who need careful control over their intake.

4. Topical Applications

While less commonly used for nausea and appetite, topical cannabis creams, balms, or transdermal patches may be beneficial for cancer patients dealing with localized pain, inflammation, or neuropathy. In some cases, patches deliver cannabinoids into the bloodstream for systemic effects, providing steady, controlled relief without psychoactive “highs.” Though not a primary method for easing nausea, topicals can complement other cannabis therapies as part of a broader symptom management plan.

5. Pharmaceutical Cannabinoids

Some patients prefer or require standardized pharmaceutical formulations. FDA-approved medications such as dronabinol (Marinol) and nabilone (Cesamet) are synthetic THC compounds prescribed for chemotherapy-induced nausea and appetite stimulation. These come in capsule form, offering consistency in dosing and ease of prescription. However, patients often report that whole-plant cannabis or balanced THC:CBD preparations feel more effective due to the entourage effect—the synergistic interaction of multiple cannabinoids and terpenes.

Choosing the Right Form

The best form of medical marijuana depends on the patient’s symptom pattern, treatment goals, and individual response. For instance:

  • A patient with sudden, unpredictable nausea may benefit most from vaporization or sublingual tinctures.

  • Someone struggling with chronic appetite loss may find edibles or capsules more practical.

  • Patients highly sensitive to THC might prefer a CBD-rich tincture to avoid psychoactive effects while still gaining some symptom relief.

Ultimately, cancer patients have options that can be personalized and flexible, something rarely possible with traditional anti-nausea and appetite drugs. This adaptability is one reason why medical marijuana continues to gain traction as a supportive therapy in oncology care.

Safety and Side Effects

Like any medication, cannabis has side effects. The most common include:

  • Dizziness

  • Fatigue

  • Dry mouth

  • Euphoria or feeling “high”

These are typically mild and manageable compared to the side effects of chemotherapy drugs. Importantly, unlike opioids, cannabis does not cause fatal respiratory depression.

Still, caution is advised for:

  • Patients with cardiovascular disease

  • Those with a history of psychosis

  • Individuals on medications that may interact with cannabinoids

Medical supervision ensures cannabis is used safely and effectively.

cannabis for cancer patients

The Future of Cannabis in Cancer Care

The field of oncology and cannabis research is rapidly evolving. Future directions include:

  • Optimizing cannabinoid ratios (e.g., THC:CBD blends).

  • Exploring minor cannabinoids like CBG and CBC for appetite and mood support.

  • Investigating terpenes (like limonene and linalool) for anti-anxiety and anti-nausea effects.

  • Developing safer delivery methods such as metered inhalers and intranasal sprays.

High-quality clinical trials are still needed, but current evidence combined with strong patient testimonials points to cannabis becoming a mainstay of supportive cancer care.

Conclusion: A Patient-Centered Option for Nausea and Appetite

For cancer patients struggling with nausea and appetite loss, medical marijuana offers real hope and practical relief. While not a cure for cancer, cannabis has demonstrated the ability to ease treatment side effects, reduce reliance on opioids and antiemetics, and restore appetite and enjoyment of food.

As research expands, it’s clear that medical marijuana deserves a place in the broader conversation about cancer care. Patients are already speaking: cannabis helps them feel better, eat better, and live with more dignity during treatment.

For those in Virginia and beyond, obtaining a medical marijuana card through trusted providers like CannabisMD TeleMed ensures safe, legal access to high-quality cannabis products. Patients deserve compassionate, evidence-based care—and cannabis is proving to be a powerful ally in that mission.

 

FAQs

  • Yes. Research shows that cannabinoids like THC and CBD can reduce chemotherapy-related nausea by interacting with brain and gut receptors that regulate vomiting. Many patients report cannabis works when standard anti-nausea medications fail, making it a valuable supportive option. However, dosing and form of use play a key role in effectiveness.

  • Cannabis, particularly THC, stimulates CB1 receptors in the brain that control hunger, often increasing food intake and interest in eating. This effect is especially important for patients struggling with weight loss or cachexia during treatment. Many patients describe cannabis as helping them enjoy food again, which can improve strength and recovery.

  • It depends on the patient’s needs. Inhaled cannabis works quickly and is helpful for sudden nausea, while edibles and capsules provide longer-lasting relief for appetite support. Tinctures and sprays offer a balance between fast onset and precise dosing, giving patients flexibility in managing symptoms.

  • Yes, though most are manageable. Common side effects include dizziness, drowsiness, dry mouth, and in some cases anxiety or paranoia at higher doses. Choosing the right formulation and starting with a low dose can help minimize these risks. Working with a medical marijuana doctor ensures safe and effective use.

  • Cannabis doesn’t replace conventional medications for everyone, but it can provide additional relief where traditional drugs fall short. Some patients even prefer cannabis because it tackles both nausea and appetite loss simultaneously. Studies suggest a combination of medical cannabis with standard treatments may offer the best results.

Headshot of Steven Fiore, MD

This article has been reviewed
by Steven Fiore, MD.

Ukeme Akpan

I have been researching and writing topics related to medical cannabis for many years. My goal is to create educational content.

Next
Next

Study Finds 86.8% of IBS and IBD Patients Report Cannabis Relieves Their Inflammation and Pains